Search Results
ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer
ESMO Daily Reporter Talk: The role of CDK4/6 inhibitors in the early stage of #breastcancer.
Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancer
Breast cancer at ESMO 2020: CDK4/6 inhibitors and checkpoint inhibitors
ESMO 2020 Expert Video Report on precision medicine in prostate cancer
Adjuvant CDK4/6 inhibition in early-stage HR-positive breast cancer | Ruth O'Regan
MONARCH 2: Overall survival results from abermaciclib plus fulvestrant in HR+ HER2- advanced bre...
Key Takeaways from ESMO: CDK4/6 Inhibitors for Metastatic HR+/HER2- Breast Cancer
ESMO 2020 Highlights on neoadjuvant ICI in early TNBC: The IMpassion031 study
Breast cancer at ESMO 2020: IMpassion131, SOLAR-1, PALLAS and more
Breast Cancer Research at ESMO 20: Erica L. Mayer, MD, MPH
#ESMO22 Highlights on abemaciclib + NSAI in HR+/HER2- advanced breast cancer: The MONARCH 3 study
